For Women With Early Breast Cancer, Herceptin Treatment Can Be Much Shorter

A large, new study shows that the treatment regimen, typically recommended for a year, can be just as effective at 6 months, reducing serious side effects and costs.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Breast Cancer Herceptin (Drug) American Society of Clinical Oncology Cambridge University side effects Genentech Inc Source Type: news